Cargando…
Shorter Total Length of Stay After Intraperitoneal Fosfomycin, Metronidazole, and Molgramostim for Complicated Appendicitis: A Pivotal Quasi-Randomized Controlled Trial
Background: We aimed to investigate the difference in the total length of hospital stay (LOS) after intraperitoneal vs. intravenous antibiotic treatment in patients with complicated appendicitis. Methods: We conducted a quasi-randomized prospective clinical trial. The intervention group received 4 g...
Autores principales: | Fonnes, Siv, Roepstorff, Søren, Holzknecht, Barbara Juliane, Olesen, Christoffer Skov, Olsen, Joachim Hjalde Halmsted, Schmidt, Line, Alder, Rasmus, Gamborg, Sara, Rasmussen, Tilde, Arpi, Magnus, Jørgensen, Lars Nannestad, Rosenberg, Jacob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214811/ https://www.ncbi.nlm.nih.gov/pubmed/32432123 http://dx.doi.org/10.3389/fsurg.2020.00025 |
Ejemplares similares
-
Intraperitoneal administration of fosfomycin, metronidazole, and granulocyte-macrophage colony-stimulating factor in patients undergoing appendectomy is safe: a phase II clinical trial
por: Fonnes, Siv, et al.
Publicado: (2019) -
Autoimmune pulmonary alveolar proteinosis in an adolescent successfully treated with inhaled rhGM-CSF (molgramostim)
por: Gajewska, Marta E., et al.
Publicado: (2018) -
Treatment of Appendicitis Could Become Even Less Invasive
por: Fonnes, Siv
Publicado: (2023) -
Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus
por: Ruan, Zijing, et al.
Publicado: (2020) -
Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats
por: Papalois, Apostolos E., et al.
Publicado: (2019)